The Netherlands-based gene therapy company uniQure NV has recruited Paul Firuta from BioBlast Pharma Inc to be its chief commercial officer. In this role he will oversee global commercial and portfolio planning. Prior to BioBlast, Mr Firuta directed commercial operations at NPS Pharmaceuticals Inc and at ViroPharma Inc, which are now both part of Shire Plc. He will report to the uniQure chief executive and be based at the company’s Lexington, Massachusetts, US facility.
uniQure announced the appointment on 3 May 2016.
Copyright 2016 Evernow Publishing Ltd